Tokyo, Japan

Kazuyuki Sugiyama


Average Co-Inventor Count = 4.8

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2004-2015

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Kazuyuki Sugiyama: Innovator in Diagnostic Methods

Introduction

Kazuyuki Sugiyama is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of diagnostics, particularly in the development of methods and kits for rapid and specific diagnosis of infections. With a total of 2 patents, his work has had a notable impact on medical technology.

Latest Patents

Sugiyama's latest patents include a detection method and a detection kit that utilize DnaK as an indicator for diagnosing infections. This innovative approach allows for rapid and specific diagnosis, enhancing the efficiency of medical testing. Additionally, he has developed novel complexes containing crosslinked avidin, which are used in analytical methods and kits. These complexes facilitate quick, convenient, and accurate analysis of compounds by leveraging the avidin-biotin reaction. The analyzing method incorporates homogeneous or heterogeneous biotin-introduced products along with crosslinked avidin, ensuring reliable results.

Career Highlights

Throughout his career, Kazuyuki Sugiyama has worked with notable organizations, including LSI Medience Corporation. His expertise in diagnostic methods has positioned him as a key figure in the field, contributing to advancements that benefit healthcare professionals and patients alike.

Collaborations

Sugiyama has collaborated with esteemed colleagues such as Atsuko Minagawa and Toyomasa Hiroshima. These partnerships have fostered innovation and have been instrumental in the development of his patented technologies.

Conclusion

Kazuyuki Sugiyama's contributions to diagnostic methods exemplify the importance of innovation in healthcare. His patents reflect a commitment to improving medical diagnostics, ultimately enhancing patient care and treatment outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…